Stephen Schultz | Vice President-Investor Relations |
Justin Gover | Chief Executive Officer |
Darren Cline | U.S. Chief Commercial Officer |
Chris Tovey | Chief Operating Officer |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
Tazeen Ahmad | Bank of America |
Cory Kasimov | JPMorgan |
David Lebowitz | Morgan Stanley |
Paul Matteis | Stifel |
Phil Nadeau | Cowen and Company |
Marc Goodman | SVB Leerink |
Esther Rajavelu | Oppenheimer and Company |
Yatin Suneja | Guggenheim Partners |
David Kideckel | AltaCorp Capital |
Danielle Brill | Piper Jaffray |
Greetings, and welcome to the GW Pharmaceuticals Second Quarter 2019 Financial Results Conference Call. [Operator Instructions] Please note, this conference is being recorded.
I’ll now turn the conference over to Mr. Stephen Schultz, VP of Investor Relations. Thank you.